Why do we need a statin trial in hemodialysis patients?
- 1 May 2003
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 63 (84), S204-S206
- https://doi.org/10.1046/j.1523-1755.63.s84.10.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective studyThe Lancet, 2001
- Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremiaKidney International, 2001
- Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairmentAmerican Journal of Kidney Diseases, 2001
- Impaired endothelium‐dependent vasodilatation in renal failure in humansNephrology Dialysis Transplantation, 2001
- Premature cardiovascular disease in chronic renal failureThe Lancet, 2000
- Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failureKidney International, 1999
- Clinical epidemiology of cardiovascular disease in chronic renal diseaseAmerican Journal of Kidney Diseases, 1998
- Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysisAtherosclerosis, 1997
- Outcome and risk factors of ischemic heart disease in chronic uremiaKidney International, 1996
- Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?Kidney International, 1994